Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation

European Journal of Heart Failure

Volumn 9, Issue 10, 2007, Pages 995-1002

  Roura, Santiago ^a   Planas, Francesc ^a   Prat Vidal, Cristina ^a   Leta, Ruben ^a   Soler Botija, Carolina ^a   Carreras, Francesc ^a   Llach, Anna ^a   Hove Madsen, Leif ^a   Pons Lladó, Guillem ^a   Farré, Jordi ^a   Cinca, Juan ^a,b   Bayes Genis, Antoni ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

catenin; Angiogenesis; EPC; Idiopathic dilated cardiomyopathy; Multi slice CT; Vasculogenesis

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOGENESIS; ARTICLE; ATROPHY; CELL MATURATION; CLINICAL ARTICLE; COLONY FORMATION; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM; ENDOTHELIUM CELL; EPICARDIUM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CELL; MYOFILAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRASTRUCTURE; VASCULARIZATION; WESTERN BLOTTING;

ADULT; BETA CATENIN; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548825964     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.07.008     Document Type: Article

References (37)

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841-2.
2. Roberts W.C., Siegel R.J., and McManus B.M. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60 (1987) 1340-1355
3. Mela T., Meyer T.E., Pape L.A., et al. Coronary arterial dimension-to-left ventricular mass ratio in idiopathic dilated cardiomyopathy. Am J Cardiol 83 (1999) 1277-1280
4. Kaufmann P., Vassalli G., Lupi-Wagner S., et al. Coronary artery dimensions in primary and secondary left ventricular hypertrophy. J Am Coll Cardiol 28 (1996) 745-750
5. Tham E., Wang J., Piehl F., et al. Upregulation of VEGF-A without angiogenesis in a mouse model of dilated cardiomyopathy caused by mitochondrial dysfunction. J Histochem Cytochem 50 (2002) 935-944
6. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9 (2003) 702-712
7. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
8. Ferrara N., Carver-Moore K., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
9. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
10. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U.S.A. 98 (2001) 10344-10349
11. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
12. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
13. Nieman K., Oudkerk M., Rensing, et al. Coronary angiography with multi-slice computed tomography. Lancet 357 (2001) 599-603
14. Mosseri M., Zolti E., Rozenman Y., et al. The diameter of the epicardial coronary arteries in patients with dilated cardiomyopathy. Int J Cardiol 62 (1997) 133-141
15. Fiaccavento R., Carotenuto F., Minieri M., et al. Stem cell activation sustains hereditary hypertrophy in hamster cardiomyopathy. J Pathol 205 (2005) 397-407
16. Soler-Botija C., Ferrer I., Alvarez J.L., et al. Downregulation of Bcl-2 proteins in type I spinal muscular atrophy motor neurons during fetal development. J Neuropathol Exp Neurol 62 (2003) 420-426
17. Hill J.M., Zalos G., Halcox, et al. Circulating EPCs, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
18. Kelly B.D., Hackett S.F., Hirota K., et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93 (2003) 1074-1081
19. Forsythe J.A., Jiang B.H., Iyer N.V., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 (1996) 4604-4613
20. Lee S.H., Wolf P.L., Escudero R., et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342 (2000) 626-633
21. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2+CD133+ endothelial precursor cells. Circ Res 88 (2001) 167-174
22. Harrison C.V., and Wood P. Hypertensive and ischemic heart disease; a comparative clinical and pathological study. Br Heart J 11 (1949) 205-229
23. Kimball B.P., Lipreti V.L., Bui S., Wigle E.D., et al. Comparison of left anterior descending and circumflex coronary artery dimensions in aortic valve stenosis and hypertrophic cardiomyopathy. Am J Cardiol 65 (1990) 767-771
24. Dodge J.T., Brown B.G., Bolson E.L., and Dodge H.T. Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation 86 (1992) 232-246
25. MacAlpin R.N., Abbasi A.S., Grollman J.H., and Eber L. Human coronary artery size during life: a cinearteriographic study. Radiology 108 (1973) 567-576
26. Urbich C., and Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14 (2004) 318-322
27. Dzau V.J., Gnecchi M., Pachori A.S., et al. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 46 (2005) 7-18
28. Shantsila E., Watson T., and Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49 (2007) 741-752
29. Unverferth D.V., Baker P.B., Swift S.E., et al. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol 57 (1986) 816-820
30. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
31. De Falco E., Porcelli D., Torella A.R., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104 (2004) 3472-3482
32. Valgimigli M., Rigolin G.M., Fucili A., et al. CD34+ and EPCs in patients with various degrees of congestive heart failure. Circulation 110 (2004) 1209-1212
33. Cattelino A., Liebner S., Gallini R., et al. The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 162 (2003) 1111-1122
34. Masckauchan T.N., Shawber C.J., Funahashi Y., et al. Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 8 (2005) 43-51
35. van Gijn M.E., Daemen M.J., Smits J.F., et al. The wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res 55 (2002) 16-24
36. Stolen K.Q., Kemppainen J., Kalliokoski K.K., et al. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 93 (2004) 64-68
37. Neglia D., Michelassi C., Trivieri M.G., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105 (2002) 186-193